Postprandial Hypoglycemia
📧 Sign up to get email alerts when something new happens for Postprandial Hypoglycemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-16Clinical Trial Update: Empagliflozin for the Treatment of Postprandial Hypoglycemia [Phase 3]
Phase 3 trial evaluating empagliflozin for postprandial hypoglycemia has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: The Scottish Fruit Study [NA]
Completed update for the University of Aberdeen's Scottish Fruit Study (NCT05513404) involving postprandial hypoglycemia and age-related mem…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Treatment of Post-bariatric Hypoglycaemia [Phase 2]
Phase 2 trial update for treatment of post-bariatric hypoglycemia.
-
CLINICAL_TRIALS trial_result · 2020-03-31Clinical Trial Update: Dasiglucagon in the Treatment of Postprandial Hypoglycaemia After Roux-en-Y Gastric Bypass [Phase 2]
Phase 2 trial evaluating dasiglucagon for postprandial hypoglycemia after Roux-en-Y gastric bypass has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Role of Glucagon-Like Peptide-1 in Postprandial Hypoglycemia [NA]
This entry reports the completion and results posting of a clinical trial evaluating the role of glucagon-like peptide-1 (GLP-1) in postpran…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.